Literature DB >> 15289750

Diagnosis of sleep apnea.

A Mattei1, G Tabbia, S Baldi.   

Abstract

Obstructive sleep apnea syndrome (OSAS) is characterized by repeated oropharyngeal occlusions occurring during sleep. The prevalence of moderate OSAS (with an apnea-hypopnea index = or >15/h) is 9% and 4% in male and female, respectively. It is associated with an abnormally high frequency of cardiovascular disease (hypertension, stroke, coronary heart disease) and excessive daytime sleepiness responsible for an increased frequency of work and road accidents. Because the treatment of OSAS provides many benefits to patients and society, it is very important to obtain an early diagnosis. The diagnosis of OSAS is based on the combination of characteristic clinical features plus compatible findings on instrumental tests in which multiple physiologic signals are monitored simultaneously during a night of sleep. A full night polysomnography, conducted by a technologist in a sleep laboratory, is the gold standard for the diagnosis of suspected OSAS, but the capacity for performing polysomnography is limited. On the basis of the high incidence and prevalence of OSAS, of the limited number of sleep laboratories, long waiting times and high costs recommendations have been formulated for the use of unattended portable systems in the assessment of OSAS. The main clinical aspects of of OSAS, the diagnostic approach with full night polysomnography and unattended portable systems, the differential diagnosis and some examples of cardiorespiratory portable monitoring are presented in this paper.

Entities:  

Mesh:

Year:  2004        PMID: 15289750

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  8 in total

1.  Neuroendocrine alterations in obese patients with sleep apnea syndrome.

Authors:  Fabio Lanfranco; Giovanna Motta; Marco Alessandro Minetto; Matteo Baldi; Marcella Balbo; Ezio Ghigo; Emanuela Arvat; Mauro Maccario
Journal:  Int J Endocrinol       Date:  2010-02-23       Impact factor: 3.257

2.  Objective Relationship Between Sleep Apnea and Frequency of Snoring Assessed by Machine Learning.

Authors:  Hisham Alshaer; Richard Hummel; Monique Mendelson; Travis Marshal; T Douglas Bradley
Journal:  J Clin Sleep Med       Date:  2019-03-15       Impact factor: 4.062

Review 3.  Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update.

Authors:  F Lanfranco; G Motta; M A Minetto; E Ghigo; M Maccario
Journal:  J Endocrinol Invest       Date:  2010-03       Impact factor: 4.256

4.  Diagnostic value of combined parameters derived from ambulatory electrocardiography for detecting coronary artery disease in non-active chest pain patients.

Authors:  Yue Jiang; Jun-Ping Tian; Hong Wang; Bu-Xing Chen; Feng-He Du
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

5.  Prevalence of Major Cardiovascular Disease Events Among People Diagnosed With Schizophrenia Who Have Sleep Disturbance, Sedentary Behavior, or Muscular Weakness.

Authors:  Alexandra Berry; Alison R Yung; Matthew J Carr; Roger T Webb; Darren M Ashcroft; Joseph Firth; Richard J Drake
Journal:  Schizophr Bull Open       Date:  2021-01-19

6.  Observational and genetic evidence highlight the association of human sleep behaviors with the incidence of fracture.

Authors:  Yu Qian; Jiangwei Xia; Ke-Qi Liu; Lin Xu; Shu-Yang Xie; Guo-Bo Chen; Pei-Kuan Cong; Saber Khederzadeh; Hou-Feng Zheng
Journal:  Commun Biol       Date:  2021-11-26

7.  Investigation of obstructive sleep apnoea syndrome prevalence among long-distance drivers from Zonguldak, Turkey.

Authors:  Muhammed E Akkoyunlu; Remzi Altın; Levent Kart; Figen Atalay; Tacettin Ornek; Mehmet Bayram; Meltem Tor
Journal:  Multidiscip Respir Med       Date:  2013-02-06

8.  Comparison of Predictor of Desaturation Disorders and Daytime Sleepiness Based On Epworth Sleepiness Scale and STOP-BANG Questionnaires in Mild to Moderate Obstructive Sleep Apnea Patients.

Authors:  Zohreh Kahramfar; Besharat Rahimi
Journal:  Open Access Maced J Med Sci       Date:  2018-08-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.